The ROC (receiver operating characteristic) analysis for PTX3 had an area under the curve of 0.928 (95% CI: 0.884–0.971, p < 0.001), which suggests that this approach could discriminate between those patients with and without CM. The gene discussed is PTX3; the disease is cutaneous mastocytosis.